Search Results
AMD 3465 Hexahydrobromide 10mg 10mg | Purity Not Available
Adooq Bioscience
P505-15 50mg 50mg | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageP505-15 5mg 5mg | Purity Not Available
Adooq Bioscience
P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PageAP26113 10mg 10mg | Purity Not Available
Adooq Bioscience
AP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageTCN 201 50mg 50mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 25mg 25mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 100mg 100mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 10mg 10mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageOC 000459 50mg 50mg | Purity Not Available
Adooq Bioscience
OC 000459 is a potent, oral and selective CRTH2 (also known as DP2) antagonist.
More Information Supplier Page